stars 1 stars 2 stars 3

Control Bionics offers a suite of dedicated speech generating devices and AAC accessories to give people living with complex communication and physical needs their voice. Our product range is more intuitive and flexible than ever, giving users the power to make life-changing connections. Control Bionics makes NeuroNode, a sixth generation computer-human-interface (CHI) system that is designed to enable people with severe disabilities to communicate with their loved ones, carers, friends and the world at large with text, text-to-speech (TTS), instant messaging (IM), emails and the internet; and to control their own entertainment media (music, videos and online services) as well as expanding their own creativity with word processing, music and video editing, and design programs.

Control Bionics (ASX:CBL) Questions

The Control Bionics (ASX:CBL) annual revenue was $11 million in 2026.

Jeremy Steele is the CEO of Control Bionics (ASX:CBL).

31 people are employed at Control Bionics (ASX:CBL).

Control Bionics (ASX:CBL) is based in Melbourne, Victoria.

The NAICS codes for Control Bionics (ASX:CBL) are [33, 334].

The SIC codes for Control Bionics (ASX:CBL) are [38, 384].

Top Control Bionics (ASX:CBL) Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users